Cell Therapy Market for Autologous Segment to Grow at Fastest CAGR during Forecast Period

According to our new market research study on “Cell Therapy Market to 2027 – Asia Pacific Analysis and Forecast – by Product Type, and End Use,” the market is expected to reach US$ 1,366.0 million by 2027 from US$ 2,449.8 million in 2019. The market is estimated to grow at a CAGR of 7.7% from 2020-2027. The report highlights trends prevailing in the Asia Pacific cell therapy Market and the drivers and restraints pertaining to the market growth.

Autologous cells propose several benefits to patients, including lowering the risk of immuno-rejection and the potential for personalized medicine. Autologous therapies are tailor made products for each patient. In autologous therapies, the cells obtained from the patient are processed on-site at the clinic or hospital. These therapies are not directed as a biologic product and not developed under Good Manufacturing Practice (GMP), but rather, the devices used to process are regulated. For instance, a RECELL equipment used to make autologous Regenerative Epidermal Suspension for direct application to acute partial-thickness thermal burn wounds. Biologic cell-based therapies to cure several diseases, like cancer, neuro disorder, and skin disease, to name a few. Many healthcare technology start-ups are active in the field of personalized cell therapy to cure diseases. For instance, in 2019, Aspen Neuroscience received US$6.5 Million seed funding to develop personalized and autologous cell therapy for Parkinson’s disease.

Vericel Corporation, MEDIPOST, NuVasive, Inc., Mesoblast Limited, JCR Pharmaceuticals Co. Ltd., Smith & Nephew, Bristol-Myers Squibb Company, Cells for Cells, Stemedica Cell Technologies, Inc, Castle Creek Biosciences, Inc. are among the leading companies operating in the Cell Therapy Market.

Asia Pacific Cell Therapy Market, By Country, 2019 (%)

The report segments Asia Pacific Cell Therapy market as follows:

By Therapy Type

• Allogeneic
• Autologous

By Product

• Consumables
• Equipment
• Systems and Software

By Technology

• Viral Vector Technology
• Genome Editing Technology
• Somatic Cell Technology
• Cell Immortalization Technology
• Cell Plasticity Technology
• Three-Dimensional Technology

By Application

• Oncology
• Cardiovascular
• Orthopedic
• Wound Management
• Other Applications

By End User

• Research Institutes
• Hospitals
• Others

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com